OBJECTIVE: To determine structural MRI and digital microscopic characteristics of REM sleep behavior disorder in individuals with low-, intermediate-, and high-likelihood dementia with Lewy bodies (DLB) at autopsy. METHODS: Patients with autopsy-confirmed low-, intermediate-, and high-likelihood DLB, according to the probability statement recommended by the third report of the DLB Consortium, and antemortem MRI, were identified (n = 75). The clinical history was assessed for presence (n = 35) and absence (n = 40) of probable REM sleep behavior disorder (pRBD), and patients' antemortem MRIs were compared using voxel-based morphometry. Pathologic burdens of phospho-tau, β-amyloid, and α-synuclein were measured in regions associated with early neuropathologic involvement, the hippocampus and amygdala. RESULTS: pRBD was present in 21 patients (60%) with high-likelihood, 12 patients (34%) with intermediate-likelihood, and 2 patients (6%) with low-likelihood DLB. Patients with pRBD were younger, more likely to be male (p ≤ 0.001), and had a more frequent neuropathologic diagnosis of diffuse (neocortical) Lewy body disease. In the hippocampus and amygdala, phospho-tau and β-amyloid burden were lower in patients with pRBD compared with those without pRBD (p < 0.01). α-Synuclein burden did not differ in the hippocampus, but trended in the amygdala. Patients without pRBD had greater atrophy of temporoparietal cortices, hippocampus, and amygdala (p < 0.001) than those with pRBD; atrophy of the hippocampus (p = 0.005) and amygdala (p = 0.02) were associated with greater phospho-tau burdens in these regions. CONCLUSION: Presence of pRBD is associated with a higher likelihood of DLB and less severe Alzheimer-related pathology in the medial temporal lobes, whereas absence of pRBD is characterized by Alzheimer-like atrophy patterns on MRI and increased phospho-tau burden.
OBJECTIVE: To determine structural MRI and digital microscopic characteristics of REM sleep behavior disorder in individuals with low-, intermediate-, and high-likelihood dementia with Lewy bodies (DLB) at autopsy. METHODS:Patients with autopsy-confirmed low-, intermediate-, and high-likelihood DLB, according to the probability statement recommended by the third report of the DLB Consortium, and antemortem MRI, were identified (n = 75). The clinical history was assessed for presence (n = 35) and absence (n = 40) of probable REM sleep behavior disorder (pRBD), and patients' antemortem MRIs were compared using voxel-based morphometry. Pathologic burdens of phospho-tau, β-amyloid, and α-synuclein were measured in regions associated with early neuropathologic involvement, the hippocampus and amygdala. RESULTS: pRBD was present in 21 patients (60%) with high-likelihood, 12 patients (34%) with intermediate-likelihood, and 2 patients (6%) with low-likelihood DLB. Patients with pRBD were younger, more likely to be male (p ≤ 0.001), and had a more frequent neuropathologic diagnosis of diffuse (neocortical) Lewy body disease. In the hippocampus and amygdala, phospho-tau and β-amyloid burden were lower in patients with pRBD compared with those without pRBD (p < 0.01). α-Synuclein burden did not differ in the hippocampus, but trended in the amygdala. Patients without pRBD had greater atrophy of temporoparietal cortices, hippocampus, and amygdala (p < 0.001) than those with pRBD; atrophy of the hippocampus (p = 0.005) and amygdala (p = 0.02) were associated with greater phospho-tau burdens in these regions. CONCLUSION: Presence of pRBD is associated with a higher likelihood of DLB and less severe Alzheimer-related pathology in the medial temporal lobes, whereas absence of pRBD is characterized by Alzheimer-like atrophy patterns on MRI and increased phospho-tau burden.
Authors: Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack Journal: Neuroimage Date: 2010-12-31 Impact factor: 6.556
Authors: Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack Journal: Neurobiol Aging Date: 2011-10-21 Impact factor: 4.673
Authors: Bradley F Boeve; Jennifer R Molano; Tanis J Ferman; Glenn E Smith; Siong-Chi Lin; Kevin Bieniek; Wael Haidar; Maja Tippmann-Peikert; David S Knopman; Neill R Graff-Radford; John A Lucas; Ronald C Petersen; Michael H Silber Journal: Sleep Med Date: 2011-02-23 Impact factor: 3.492
Authors: Brittany N Dugger; Bradley F Boeve; Melissa E Murray; Joseph E Parisi; Hiroshige Fujishiro; Dennis W Dickson; Tanis J Ferman Journal: Mov Disord Date: 2011-10-28 Impact factor: 10.338
Authors: T J Ferman; B F Boeve; G E Smith; S-C Lin; M H Silber; O Pedraza; Z Wszolek; N R Graff-Radford; R Uitti; J Van Gerpen; W Pao; D Knopman; V S Pankratz; K Kantarci; B Boot; J E Parisi; B N Dugger; H Fujishiro; R C Petersen; D W Dickson Journal: Neurology Date: 2011-08-17 Impact factor: 9.910
Authors: Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack Journal: Brain Date: 2007-01-31 Impact factor: 13.501
Authors: Nicholas J Janocko; Kevin A Brodersen; Alexandra I Soto-Ortolaza; Owen A Ross; Amanda M Liesinger; Ranjan Duara; Neill R Graff-Radford; Dennis W Dickson; Melissa E Murray Journal: Acta Neuropathol Date: 2012-09-12 Impact factor: 17.088
Authors: Zuzana Nedelska; Tanis J Ferman; Bradley F Boeve; Scott A Przybelski; Timothy G Lesnick; Melissa E Murray; Jeffrey L Gunter; Matthew L Senjem; Prashanti Vemuri; Glenn E Smith; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Kejal Kantarci Journal: Neurobiol Aging Date: 2014-07-15 Impact factor: 4.673
Authors: Marina Buciuc; Alexandra M Wennberg; Stephen D Weigand; Melissa E Murray; Matthew L Senjem; Anthony J Spychalla; Bradley F Boeve; David S Knopman; Clifford R Jack; Kejal Kantarci; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Jennifer L Whitwell; Keith A Josephs Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Zuzana Nedelska; Christopher G Schwarz; Bradley F Boeve; Val J Lowe; Robert I Reid; Scott A Przybelski; Timothy G Lesnick; Jeffrey L Gunter; Matthew L Senjem; Tanis J Ferman; Glenn E Smith; Yonas E Geda; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: Neurobiol Aging Date: 2015-03-14 Impact factor: 4.673
Authors: Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: Alzheimers Dement Date: 2016-08-10 Impact factor: 21.566
Authors: Lidia Sarro; Matthew L Senjem; Emily S Lundt; Scott A Przybelski; Timothy G Lesnick; Jonathan Graff-Radford; Bradley F Boeve; Val J Lowe; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: Brain Date: 2016-07-24 Impact factor: 13.501
Authors: Christine M Belden; Vickram Kahlon; Michael Malek-Ahmadi; Andrew Tsai; Marwan N Sabbagh Journal: Am J Alzheimers Dis Other Demen Date: 2014-07-09 Impact factor: 2.035